Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Future of the Older Patients After Intensive Care Unit (DAAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02849756
Recruitment Status : Completed
First Posted : July 29, 2016
Last Update Posted : July 29, 2019
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier René Dubos

Brief Summary:
Estimate the future six months after the admission in an intensive care unit of the patients of 85 and more years old in terms of autonomy.

Condition or disease Intervention/treatment
Intensive Care Unit Syndrome Other: older in intensive care unit

Detailed Description:

The diverse studies published on the future of the elderly hospitalized in resuscitation place the limit very low, between 65 and 80 years. The feeling of a very bad forecast at these extreme ages pulls nevertheless a filter in the admission in ICU which has this day no scientific justification. The knowledge of the evolution after the hospitalization of these older patients can help to make certain decisions concerning as well the admission of these patients in ICU as the realization of invasive treatments.

After informal interrogation of numerous intensivists, it seems to take shape a bar around 85 years beyond which the forecast would be worse without more proof what consolidated the choice of this limit.

The reserved scores were already used in similar studies (simplified ALD).

Primary purpose :

  • Describe the survival and the evolution of the quality of life after a stay in resuscitation for very old patients.
  • The quality of life will be studied through a score of autonomy: the simplified ALD score.

The population will be described in general then by age bracket (more or less of 90 years old), according to the length of stay in ICU, the heavy treatments (artificial ventilation, renal replacement therapy) practiced, the initial gravity (score IGS 2). The impact of possible decisions of Limitation or Stop of Therapeutic Activates will also be taken into account.


Layout table for study information
Study Type : Observational
Actual Enrollment : 240 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Future of the Older Patients After Intensive Care Unit
Study Start Date : February 2015
Actual Primary Completion Date : June 2017
Actual Study Completion Date : June 2017

Group/Cohort Intervention/treatment
older in intensive care unit
older (age superior at 85 years) hospitalized in intensive care unit. A follow-up until 6 months after hospitalization will determine the evolution of the quality of life and others secondary outcomes.
Other: older in intensive care unit
It is an observational study with no intervention.




Primary Outcome Measures :
  1. ALD score [ Time Frame: Six month ]
    Geriatric score of autonomy


Secondary Outcome Measures :
  1. survival [ Time Frame: Six month ]
    survival



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   85 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients older than 85 years hospitalized in intensive care unit will be included in this study.
Criteria

Inclusion Criteria:

  • All patients over 85 years old staying in intensive car units

Exclusion Criteria:

  • Knaus D
  • No possibly of call (phone) 6 months after ICU admission
  • Patients who do not speak French
  • Patients do not accept the participation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02849756


Locations
Layout table for location information
France
René-Dubos Hospital
Pontoise, Val d'Oise, France, 95303
Sponsors and Collaborators
Centre Hospitalier René Dubos
Investigators
Layout table for investigator information
Principal Investigator: Philippe Dr MICHEL, PH René-Dubos Hospital